Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
ePurines Logo
ePurines Growth Score
35
CB Rank
195185
Heat Score
47
ePurines is a drug development company focused on purinergic-based therapies for obesity, metabolic syndrome renal and liver diseases.
Founded
obfuscation
PrivateSeed Sandy, Utah, United States1-10 www.epurines.com/
Biotechnology
Medical
Therapeutics
Overview

ePurines
Total Funding
obfuscation
Growth Score
35
Heat Score
47

Total Funding
obfuscation
Seed raised
obfuscation
Growth Score35
-1 pts
in past quarter
Heat Score 47
-12 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About ePurines

CB Rank
195185
ePurines is a drug development company focused on purinergic-based therapies for obesity, metabolic syndrome renal and liver diseases.
Founded
obfuscation
PrivateSeed Sandy, Utah, United States1-10 www.epurines.com/
Biotechnology
Medical
Therapeutics

Funding Rounds

Seed
OBF
in
obfuscation
Pre-Seed
OBF
in
obfuscation

Key People

Details

Legal Name ePurines, Inc
Operating Status Active
Company Type For Profit
Founders  B. K. Kishore, Simon Robson
About the Company
ePurines, Inc is a drug development company focused on innovative purinergic-based therapies for obesity, metabolic syndrome renal and liver diseases.
Phone Number 801-598-3389
Contact Email epurines@gmail.com
Predictions & Insights

Products & Services

P2Y2 Receptor Antagonists for Nephrogenic Diabetes Insipidus (NDI)
Small molecule drugs targeting P2Y2 receptor to treat lithium-induced nephrogenic diabetes insipidus by modulating renal salt and water transport.
P2Y2 Receptor Antagonists for Diet-Induced Obesity
Orally effective small molecule drugs targeting P2Y2 receptor to prevent or treat obesity by affecting adipogenesis, inflammation, insulin resistance, and energy metabolism.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - ePurines Logo
Seed Round - ePurines
1
obfuscation
Altitude LabSeed
obfuscation
Seed Round - ePurines Logo
Seed Round - ePurines
1
obfuscation
Altitude LabSeed
obfuscation
Seed Round - ePurines Logo
Seed Round - ePurines
1
obfuscation
Altitude LabSeed
obfuscation
Seed Round - ePurines Logo
Seed Round - ePurines
1
obfuscation
Altitude LabSeed
obfuscation
Seed Round - ePurines Logo
Seed Round - ePurines
1
obfuscation
Altitude LabSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - ePurines Logo
Seed Round - ePurines
1
obfuscation
Altitude LabSeed
obfuscation
Seed Round - ePurines Logo
Seed Round - ePurines
1
obfuscation
Altitude LabSeed
obfuscation
Seed Round - ePurines Logo
Seed Round - ePurines
1
obfuscation
Altitude LabSeed
obfuscation
Seed Round - ePurines Logo
Seed Round - ePurines
1
obfuscation
Altitude LabSeed
obfuscation
Seed Round - ePurines Logo
Seed Round - ePurines
1
obfuscation
Altitude LabSeed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Altitude Lab Logo
Altitude Lab
Yes
Seed Round - ePurines Logo
Seed Round - ePurines
Chandana Haque
Altitude Lab Logo
Altitude Lab
Yes
Seed Round - ePurines Logo
Seed Round - ePurines
Chandana Haque
Altitude Lab Logo
Altitude Lab
Yes
Seed Round - ePurines Logo
Seed Round - ePurines
Chandana Haque
Altitude Lab Logo
Altitude Lab
Yes
Seed Round - ePurines Logo
Seed Round - ePurines
Chandana Haque
Altitude Lab Logo
Altitude Lab
Yes
Seed Round - ePurines Logo
Seed Round - ePurines
Chandana Haque
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3

Employee Profiles

News

News and Press

News•Jun 2, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

146

IT Spend

$56.7KThis year, ePurines is projected to spend $56.7K on IT, according to Aberdeen.

Active Website Tech Count

21ePurines is actively using 21 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m, Euro, and  Google Tag Manager.
Sub-Organizations
Frequently Asked Questions

Where is ePurines's headquarters? ePurines is located in Sandy, Utah, United States.Who invested in ePurines? ePurines is funded by Altitude Lab.When was the last funding round for ePurines? ePurines closed its last funding round on
obfuscation
from a Seed round.Who are ePurines's competitors? Alternatives and possible competitors to ePurines may include Metsera, Fractyl Health, and  Nimbus Therapeutics.How much funding has ePurines raised to date? ePurines has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(9fd75b2 1)
|